Note: Ingredients listed on restricted chemical lists
EC/CAS
231-668-3/7681-52-9
Name of the chemical
Sodium hypochlorite
Concentration
4.0-6.5
General Information
Version
4.2
Revision date
2023-10-24
Product name
HYPO-CHLOR 5.25%
Emergency telephone
+1 610-644-8335, +1 610-644-8336, +91 22-43560400, +44 (0)1235 239 670, +44 (0)1235 239 671, +353 1 809 2566, +353 1 809 2166
Icons in SDS
Company Information
company name
Veltek Associates, Inc
e-mail address of the competent person responsible for the Safety Data Sheet
vai@sterile.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H290, H315, H318, H400, H410, H411
Hazard statements
Code
Statements
H290
May be corrosive to metals
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Hazard pictograms
GHS05 GHS09
Signal word
Danger
Hazard statements
H290 - May be corrosive to metals. H315 - Causes skin irritation. H318 - Causes serious eye damage. H410 - Very toxic to aquatic life with long lasting effects.
Precautionary statements
P234 - Keep only in original packaging. P280 - Wear eye protection, protective clothing, protective gloves, face protection. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 - Immediately call a doctor. P390 - Absorb spillage to prevent material damage. P501 - Dispose of contents and container to an authorised waste collection point.
Supplemental label elements
EUH031 - Contact with acids liberates toxic gas.
2.3 Other hazards
This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %